Non-insulin patch pumps, also known as bolus injectors or large volume wearable injectors, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.

The global Non-insulin Patch Pumps market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Non-insulin Patch Pumps volume and value at global level, regional level and company level. From a global perspective, this report represents overall Non-insulin Patch Pumps market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Non-insulin Patch Pumps in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Non-insulin Patch Pumps manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
West Pharmaceuticals
Unilife Corporation
CeQur
Sensile Medical AG
BD Medical
Enable Injections
Roche Laboratories
scPharmaceuticals
SteadyMed Therapeutics
Johnson & Johnson

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Electronical Injectors
Mechanical Injectors
Others

Segment by Application
Cancer Treatment
Auto-immune Treatment
Blood Disorders Treatment
Others